Jie D’Elia is Chief Executive Officer and a member of the Board of Directors of Link Cell Therapies. She brings extensive leadership experience across company building, clinical development and business development at emerging and global biopharmaceutical companies. Jie previously served as Chief Executive Officer of SystImmune, Inc., a clinical-stage biopharmaceutical company developing multi-specific antibodies and […] The post Jie D’Elia, Ph.D.